What is Emulate?
Established in 2013 and headquartered in Boston, Massachusetts, Emulate is at the forefront of commercializing Organs-on-Chips technology. This innovative human cell-based platform recreates organ-level function, enabling researchers to model organs in both healthy and diseased states. Emulate's technology offers a more predictive and physiologically relevant alternative to traditional animal models, facilitating advancements in understanding disease mechanisms and accelerating the development of new therapeutics.
How much funding has Emulate raised?
Emulate has raised a total of $169M across 7 funding rounds:
Series A
$12M
Series B
$17M
Grant
$2M
Private Equity
$745K
Series C
$36M
Other Financing Round
$19.3M
Series E
$82M
Series A (2014): $12M with participation from NanoDimension and Cedars-Sinai
Series B (2016): $17M led by NanoDimension, Cedars-Sinai, ALS Finding a Cure, ATEL Capital Group, OS Fund, and Laboratory Corporation of Americau00ae Holdings
Grant (2017): $2M supported by National Center for Advancing Translational Sciences
Private Equity (2017): $745K, investors not publicly disclosed
Series C (2018): $36M backed by ALS Investment Fund, SciFi VC, Starlight Ventures, and Founders Fund
Other Financing Round (2020): $19.3M with participation from Northpond Ventures LLC, NanoDimension, Cedars-Sinai, Blue Ivy Ventures, ALSInvestment Fund, and Founders Fund LLC
Series E (2021): $82M led by Perceptive Advisors and Northpond Ventures
Key Investors in Emulate
NanoDimension
ND Capital is a venture capital firm established in 2002 that focuses on investing in disruptive technologies across life, physical, and data sciences. With $800M in assets under management, the firm operates in the United States and Europe, leveraging its teams in Silicon Valley, Switzerland, and the Cayman Islands to support portfolio companies in attracting capital and talent.
Cedars-Sinai
Founded 1902 Cedars-Sinai Medical Center is a non-profit academic medical centers in the U.S., Cedars-Sinai has clinical programs ranging from primary care to specialized treatments for rare, complex and advanced illnesses. In addition, Cedars-Sinai serves the community through its Medical Network and through wide-ranging programs that improve the health of the most vulnerable residents of Los Angeles.
Founders Fund
Founders Fund invests in the world's most important and valuable companies across all geographies, sectors and stages. The firm's partners have been founders and early funders of companies including PayPal, SpaceX, Palantir, Anduril, Airbnb, Stripe and Facebook.
What's next for Emulate?
With its substantial backing, Emulate is poised for significant expansion. The company's focus on developing advanced organ models suggests a strategic direction towards broader adoption in pharmaceutical research, clinical diagnostics, and personalized medicine. Future endeavors will likely involve scaling production, enhancing the range of organ models available, and forging deeper partnerships within the life sciences and healthcare industries to translate its technological prowess into tangible patient benefits.
See full Emulate company page
